MD Magazine: Specialty: neurology Copyright (c) 2015 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/specialty/neurology/rss neurology en-us Mon, 29 May 2017 17:10:31 +0000 the case against aggressive and induction therapy for multiple sclerosis http://www.mdmag.com/conferences/cmsc-2017/the-case-against-aggressive-and-induction-therapy-for-multiple-sclerosis Sun, 28 May 2017 15:27:00 +0000 john dirk nieland on discovering lipid metabolisms role in ms http://www.mdmag.com/conferences/cmsc-2017/john-dirk-nieland-on-discovering-lipid-metabolisms-role-in-ms Sun, 28 May 2017 01:24:00 +0000 the responsibility of strong ms treatment and children patients http://www.mdmag.com/conferences/cmsc-2017/the-responsibility-of-strong-ms-treatment-and-children-patients Sat, 27 May 2017 19:02:00 +0000 degenerative conditions in pediatric ms worsened by limited case studies http://www.mdmag.com/conferences/cmsc-2017/degenerative-conditions-in-pediatric-ms-worsened-by-limited-case-studies Fri, 26 May 2017 22:29:00 +0000 oral molecule trial shows promise in ms relapse reduction http://www.mdmag.com/conferences/cmsc-2017/oral-molecule-trial-shows-promise-in-ms-relapse-reduction Fri, 26 May 2017 22:20:00 +0000 alemtuzumab improves rrms activity over 6 years study says http://www.mdmag.com/conferences/cmsc-2017/alemtuzumab-improves-rrms-activity-over-6-years-study-says Fri, 26 May 2017 20:46:00 +0000 jeffrey cohen md discusses new ms criteria http://www.mdmag.com/conferences/cmsc-2017/jeffrey-cohen-md-discusses-new-ms-criteria Fri, 26 May 2017 18:35:00 +0000 qa fred lublin md on new ms treatment combination therapy and nervous system repair http://www.mdmag.com/conferences/cmsc-2017/qa-fred-lublin-md-on-new-ms-treatment-combination-therapy-and-nervous-system-repair Fri, 26 May 2017 16:59:00 +0000 alemtuzumab ocrelizumab prove better against relapsing ms in indirect study http://www.mdmag.com/conferences/cmsc-2017/alemtuzumab-ocrelizumab-prove-better-against-relapsing-ms-in-indirect-study Fri, 26 May 2017 16:07:00 +0000 stephen krieger md talks ocrelizumab in rrms and ppms treatment http://www.mdmag.com/conferences/cmsc-2017/stephen-krieger-md-talks-ocrelizumab-in-rrms-and-ppms-treatment Thu, 25 May 2017 17:52:00 +0000 the broad spectrum of marijuana and alternative treatment on ms http://www.mdmag.com/conferences/cmsc-2017/the-broad-spectrum-of-marijuana-and-alternative-treatment-on-ms Thu, 25 May 2017 14:33:00 +0000 the hidden role of testosterone in multiple sclerosis http://www.mdmag.com/conferences/cmsc-2017/the-hidden-role-of-testosterone-in-multiple-sclerosis Wed, 24 May 2017 23:20:00 +0000 interdisciplinary patient centered comprehensive care necessary for ms treatment http://www.mdmag.com/conferences/cmsc-2017/interdisciplinary-patient-centered-comprehensive-care-necessary-for-ms-treatment Wed, 24 May 2017 21:15:00 +0000 racial and ethnic minorities less likely to see neurologist http://www.mdmag.com/medical-news/racial-and-ethnic-minorities-less-likely-to-see-neurologist Wed, 24 May 2017 18:38:00 +0000 medical records flag future multiple sclerosis patients 5 years before onset http://www.mdmag.com/medical-news/medical-records-flag-future-multiple-sclerosis-patients-5-years-before-onset Tue, 23 May 2017 15:54:00 +0000 oral ozanimod tests better than interferon treatment for rms http://www.mdmag.com/medical-news/oral-ozanimod-tests-better-than-interferon-treatment-for-rms Mon, 22 May 2017 19:07:00 +0000 multiple sclerosis patients cognition improved by brain training http://www.mdmag.com/medical-news/multiple-sclerosis-patients-cognition-improved-by-brain-training Mon, 22 May 2017 18:02:00 +0000